Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,006.50 +139.89 (+0.23%) CMC Crypto 200
1,265.25 -92.76 (-6.83%)
Gyre Therapeutics, Inc. (GYRE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.27B |
| Enterprise value | 1.23B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.60 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 349.09% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 30.40 |
| 52-week low 3 | 3.15 |
| 50-day moving average 3 | 16.84 |
| 200-day moving average 3 | 13.98 |
Share statistics
| Avg vol (3-month) 3 | 74.53k |
| Avg vol (10-day) 3 | 53.95k |
| Shares outstanding 5 | 85.47M |
| Implied shares outstanding 6 | 87.83M |
| Float 8 | 15.63M |
| % held by insiders 1 | 81.77% |
| % held by institutions 1 | 0.73% |
| Shares short (30 Apr 2024) 4 | 76.07k |
| Short ratio (30 Apr 2024) 4 | 1.03 |
| Short % of float (30 Apr 2024) 4 | 1.19% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.09% |
| Shares short (prior month 28 Mar 2024) 4 | 121.19k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 12 Jan 2023 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 31 Oct 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -75.76% |
| Operating margin (ttm) | 29.70% |
Management effectiveness
| Return on assets (ttm) | 11.03% |
| Return on equity (ttm) | -85.40% |
Income statement
| Revenue (ttm) | 115.69M |
| Revenue per share (ttm) | 1.63 |
| Quarterly revenue growth (yoy) | 3.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 21.73M |
| Net income avi to common (ttm) | -87.64M |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | 34.00% |
Balance sheet
| Total cash (mrq) | 37.35M |
| Total cash per share (mrq) | 0.44 |
| Total debt (mrq) | 275k |
| Total debt/equity (mrq) | 0.31% |
| Current ratio (mrq) | 3.22 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.